Aims We hypothesised that omega‐3 fatty acids would be an appropriate adjunct therapy for
alleviating the inflammatory response and clinical manifestation in hospitalised patients with …

Background Omega-3 polyunsaturated fatty acids (n3-PUFAs) may exert beneficial effects
on the immune system of patients with viral infections. This paper aimed to examine the …

Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (COVID-19). SARS-CoV-2 triggers an immune response with …

In around 10% of SARS-CoV-2 infected patients, coronavirus disease-2019 (Covid-19)
symptoms are complicated with a severe lung damage called Acute Respiratory Distress …

Studies have shown that infection, excessive coagulation, cytokine storm, leukopenia,
lymphopenia, hypoxemia and oxidative stress have also been observed in critically ill …

Background Covid-19 mortality is largely associated with a severe increase in inflammatory
cytokines and polyunsaturated fatty acids (PUFAs) play an important role in modulating …

The rapid international spread of severe acute respiratory syndrome coronavirus 2
responsible for coronavirus disease 2019 (COVID-19) has posed a global health emergency …

COVID-19 can cause fever, cough, headache, and shortness of breath but patients with
comorbidities can experience worsening and death. An action is needed to treat this …

Background Omega-3 may alleviate the severity of coronavirus disease 2019 (COVID-19) by
reducing the C-reactive protein (CRP) level, a marker for systemic inflammation. Because …

Dear Editor, COVID-Omega-F (“Resolving inflammatory storm in COVID-19 patients by
Omega-3 Polyunsaturated fatty acids”) is a randomized controlled trial on intravenous (iv) …